UCLA researchers detail how prostate cancers grow more aggressively to evade treatment
The study could lead to new therapies that prevent formation of some of the most lethal forms of the disease.
cancer
Results
UCLA chemists use oxygen, copper ‘scissors’ to make cheaper drug treatments possible
The groundbreaking process cuts carbon bonds to convert organic molecules into biologically active amine molecules.
Hospitals serving large Black, Latino populations have fewer resources for cancer care
A UCLA study shows these facilities are much less likely than others to offer the full range of core cancer services.
Can cannabis-based meds help people manage oral cancer pain?
A UCLA Dentistry–led team has received a $5 million federal grant to develop an effective, non-addictive synthetic cannabinoid.
Study could help explain why certain brain tumors don’t respond well to immunotherapy
Immune checkpoint blockade has been ineffective for treating glioblastoma; UCLA-led research may reveal why.
Immunotherapy drug combo helps extend lives of people with metastatic melanoma
The finding is from a multicenter study co-led by Dr. Antoni Ribas and a team of UCLA researchers.
Cost of translating documents could be a barrier to underrepresented groups in clinical trials
A UCLA study identified an “addressable weakness” related to patient consent paperwork.
New drug delays progression of glioma, a deadly brain cancer
A study co-led by UCLA is the first clinical trial analyzing a targeted therapy specifically developed to treat brain tumors.
A metabolic process in cancer cells could unlock a possible treatment for glioblastoma
A UCLA-led study could lead to a new strategy for treating the aggressive form of brain cancer.
$5 million gift from Nancy and Howard Marks endows chair in women’s health research at UCLA
The inaugural chair holder is Dr. Beth Karlan, a UCLA professor of obstetrics and gynecology.
UCLA study on immune cell response could lead to more effective immunotherapy
Jonsson Comprehensive Cancer Center scientists adapted advanced gene-editing technology to make their observations.
Tiny implantable device designed by UCLA scientists helps kill cancer
A therapeutic sponge the size of a pencil eraser boosted tumor-fighting responses in mice and kept cancer from returning.
UCLA researchers identify gene as potential target in treatment-resistant brain cancer
The discovery could be a step toward improved treatment for glioblastoma multiforme.
‘Glass bubble’ nanocarrier boosts effects of combination therapy for pancreatic cancer
When two drugs were delivered in one nanoparticle rather than separately, the treatment worked better in mice.
These pesticides may increase cancer risk in children
Research led by UCLA links prenatal exposure to specific chemicals to higher rates of eye cancer.
Cell therapy could improve bone marrow transplant safety
A new study in mice suggests that adding iNKT cells to a stem cell transplant could reduce complication severity.
UCLA-led team creates first comprehensive map of human blood stem cell development
The study could eventually lead to more treatment options for leukemia, sickle cell disease and other conditions.
Potential glioblastoma treatment has roots in UCLA graduate research
The oral medication, ERAS-801, targets a rogue gene found in about 60% of people with the aggressive form of brain cancer.
UCLA scientists identify biomarker signature that predicts side effects from some cancer treatments
The findings could improve doctors’ ability to offer truly personalized cancer therapy.
Signaling mechanisms in pancreatic cancer cells could provide new target for treatment
A UCLA study suggests that new small-molecule drugs that inhibit a protein called ATR could be used in combination with interferon “amplification.”
Too many firefighters are dying of cancer. UCLA’s Derek Urwin aims to change that
The veteran firefighter, who expects to earn his Ph.D. in chemistry in winter quarter, is using his knowledge to improve the health and safety of his colleagues.
UCLA scientists make strides toward an ‘off-the-shelf’ immune cell therapy for cancer
Using stem cell engineering and organoid technology, UCLA researchers were able to produce large quantities of powerful cancer-fighting iNKT cells.
Eliminating RNA-binding protein improves survival in aggressive leukemia
A team led by UCLA scientists found that removing IGF2BP3 selectively targets cancer cells while leaving healthy cells alone.
Drug commonly used as antidepressant helps fight cancer in mice
UCLA researchers discover that MAOIs could activate immune system to shrink various types of tumors.
UCLA team discovers how to restrict growth, spread of head and neck cancers
The research, conducted on mice, targets a newly discovered molecular “checkpoint” that enables cancer stem cells to evade the immune system.